{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:17Z","timestamp":1792806137499,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ygyno.2026.08.018","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:11:58Z","timestamp":1788883918000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Planning and feasibility of phase III surgical trials in gynecologic oncology"],"prefix":"10.1016","volume":"213","author":[{"given":"Alexandra S.","family":"Bercow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Agusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Knisely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Harter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fagotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alejandro","family":"Rauh-Hain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2026.08.018_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0039-6060(05)80359-9","article-title":"Should we be performing more randomized controlled trials evaluating surgical operations?","volume":"118","author":"Solomon","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SLA.0b013e3181cf863d","article-title":"Randomized controlled trials of surgical interventions","volume":"251","author":"Farrokhyar","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0015","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM198707163170304","article-title":"Equipoise and the ethics of clinical research","volume":"317","author":"Freedman","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jgyn.2011.02.009","article-title":"Impact des curages r\u00e9trop\u00e9riton\u00e9aux sur la survie des patientes atteintes d\u2019un cancer de l\u2019ovaire \u00e0 un stade avanc\u00e9\u00a0: le protocole CARACO","volume":"40","author":"Classe","year":"2011","journal-title":"J. Gynecol. Obstet. Biol. Reprod."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0035","doi-asserted-by":"crossref","first-page":"e2250996","DOI":"10.1001\/jamanetworkopen.2022.50996","article-title":"Analysis of rates of completion, delays, and participant recruitment in randomized clinical trials in surgery","volume":"6","author":"Shadbolt","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa2308900","article-title":"Simple versus radical hysterectomy in women with low-risk cervical cancer","volume":"390","author":"Plante","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150205","article-title":"Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework","volume":"11","author":"Eldridge","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-071094","article-title":"How do pilot and feasibility studies inform randomised placebo-controlled trials in surgery? A systematic review","volume":"13","author":"Cousins","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0055","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bjs.11167","article-title":"Value of surgical pilot and feasibility study protocols","volume":"106","author":"Fairhurst","year":"2019","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0065","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.46325","article-title":"Laparoscopic cytoreduction after neoadjuvant chemotherapy in high-grade epithelial ovarian Cancer: a LANCE randomized clinical trial","volume":"7","author":"Rauh-Hain","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0070","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian Cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2019.10.009","article-title":"GOG 244-the lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients","volume":"156","author":"Carlson","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0080","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ygyno.2013.07.082","article-title":"A review of complications associated with the surgical treatment of vulvar cancer","volume":"131","author":"Wills","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0085","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0090","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/ijgc-2023-004377","article-title":"TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol","volume":"33","author":"Steenbeek","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0095","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00268-023-07124-z","article-title":"Methods of recruitment for surgical and perioperative randomized controlled trials: a rapid review","volume":"47","author":"Ninomiya","year":"2023","journal-title":"World J. Surg."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3390\/curroncol28010062","article-title":"Integrating patient-centred research in the Canadian cancer trials group","volume":"28","author":"Needham","year":"2021","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ygyno.2026.08.018_bb0105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0140-6736(19)33137-X","article-title":"Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)","volume":"395","author":"Beard","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jama.2019.7059","article-title":"Incorporating patient preferences in noninferiority trials","volume":"322","author":"Acuna","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2026.08.018_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1472-6939-14-28","article-title":"Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials","volume":"14","author":"Nishimura","year":"2013","journal-title":"BMC Med. Ethics"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825826021104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:12:35Z","timestamp":1792804355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825826021104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":23,"alternative-id":["S0090825826021104"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Planning and feasibility of phase III surgical trials in gynecologic oncology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2026.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}